SCHEMBL25028656

SCHEMBL25028656

CC(=O)N1CCC(Oc2ccc(-c3c[nH]c4c(C#N)cccc34)nc2C(F)(F)F)C1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NFATC1 O95644 1/20 0.40
▸ GSK3B P49841 1/20 0.40
▸ DYRK1A Q13627 1/20 0.40
▸ CYP11B1 P15538 2/20 0.39
▸ CYP11B2 P19099 2/20 0.39
▸ BTK Q06187 1/20 0.39
▸ SOS1 Q07889 1/20 0.38
▸ TBK1 Q9UHD2 8/20 0.37
▸ CCNT1 O60563 1/20 0.37
▸ CCNK O75909 1/20 0.37
▸ CCNE1 P24864 1/20 0.37
▸ CDK2 P24941 1/20 0.37
▸ CDK9 P50750 1/20 0.37
▸ CDK12 Q9NYV4 1/20 0.37
▸ PGR P06401 1/20 0.36
▸ CYP2D6 P10635 1/20 0.36
▸ CYP2C9 P11712 1/20 0.36
▸ CTSS P25774 1/20 0.35
▸ CTSK P43235 1/20 0.35
▸ NOS3 P29474 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29364633 1.00 NFATC1 (0.40) NFATC1GSK3BDYRK1ACYP11B1CYP11B2
SCHEMBL26717749 0.89 NFATC1 (0.43) NFATC1GSK3BDYRK1ACYP11B1CYP11B2
SCHEMBL29361860 0.88 NFATC1 (0.43) NFATC1GSK3BDYRK1ACYP11B1CYP11B2
SCHEMBL25029295 0.88 NFATC1 (0.43) NFATC1GSK3BDYRK1ACYP11B1CYP11B2
SCHEMBL29361305 0.88 BTK (0.41) NFATC1GSK3BDYRK1ACYP11B1CYP11B2
SCHEMBL25029073 0.88 BTK (0.41) NFATC1GSK3BDYRK1ACYP11B1CYP11B2
SCHEMBL25029076 0.88 NFATC1 (0.42) NFATC1GSK3BDYRK1ACYP11B1CYP11B2
SCHEMBL29364124 0.88 NFATC1 (0.42) NFATC1GSK3BDYRK1ACYP11B1CYP11B2
SCHEMBL25029275 0.81 CCNT1 (0.47) NFATC1GSK3BDYRK1ATBK1CCNT1
SCHEMBL29363798 0.81 CCNT1 (0.47) NFATC1GSK3BDYRK1ATBK1CCNT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230348439-A1 INDOLE COMPOUNDS AS ANDROGEN RECEPTOR MODULATORS NIDO BIOSCIENCES INC (US) 2023-11-02 — — US disclosed
US-11667624-B2 Indole compounds as androgen receptor modulators NIDO BIOSCIENCES, INC. (US) 2023-06-06 — — US disclosed
CN-115996926-A Indole compounds as androgen receptor modulators 尼多生物科学有限公司 2023-04-21 — — CN disclosed
US-20230049406-A1 INDOLE COMPOUNDS AS ANDROGEN RECEPTOR MODULATORS NIDO BIOSCIENCES, INC. 2023-02-16 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230049406-A1 INDOLE COMPOUNDS AS ANDROGEN RECEPTOR MODULATORS AR, FSHR, NR5A1 NFATC1 1397/4885GSK3B 463/4885DYRK1A 1187/4885
US-20230348439-A1 INDOLE COMPOUNDS AS ANDROGEN RECEPTOR MODULATORS AR, FSHR, NR5A1 NFATC1 1359/4885GSK3B 441/4885DYRK1A 1097/4885
US-11667624-B2 Indole compounds as androgen receptor modulators AR, FSHR, ADRB3 NFATC1 1507/4885GSK3B 468/4885DYRK1A 937/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback